International Biotechnology (LON:IBT) Insider Gillian Elcock Purchases 1,407 Shares

International Biotechnology (LON:IBT) insider Gillian Elcock bought 1,407 shares of the stock in a transaction that occurred on Wednesday, July 24th. The stock was bought at an average cost of GBX 709 ($9.17) per share, for a total transaction of £9,975.63 ($12,901.75).

International Biotechnology Stock Performance

LON IBT traded down GBX 4 ($0.05) during trading on Wednesday, reaching GBX 702 ($9.08). 42,076 shares of the company’s stock were exchanged, compared to its average volume of 59,967. The business has a 50 day moving average price of GBX 652.66 and a 200-day moving average price of GBX 650.42. The stock has a market capitalization of £274.76 million, a P/E ratio of 672.38 and a beta of 0.18. The company has a debt-to-equity ratio of 8.19, a current ratio of 0.27 and a quick ratio of 0.32. International Biotechnology has a fifty-two week low of GBX 548 ($7.09) and a fifty-two week high of GBX 718 ($9.29).

International Biotechnology Increases Dividend

The company also recently disclosed a dividend, which will be paid on Friday, August 23rd. Stockholders of record on Thursday, July 25th will be issued a dividend of GBX 14.50 ($0.19) per share. This represents a dividend yield of 2.28%. The ex-dividend date of this dividend is Thursday, July 25th. This is a boost from International Biotechnology’s previous dividend of $13.90. International Biotechnology’s payout ratio is currently 2,666.67%.

International Biotechnology Company Profile

International Biotechnology Trust plc specializes in investments in development stage and late stage companies. The majority of the fund's assets are generally invested in smaller and mid-capitalization quoted companies, with a minority in larger capitalization quoted companies. It makes long only investments.